DEV Community: Yanming Liu

CD&R and GTCR Abandon $40 Billion Global Payments Buyout as Shares Fall 12%

Yanming Liu — Fri, 13 Nov 2026 17:32:27 +0000

Global Payments is one of the largest payments processors in the world, handling card and digital transactions for merchants while selling software and technology services that sit alongside the payment itself. The Atlanta-based company had a market value of about $26.4 billion, Reuters reported on November 12, 2026, a valuation that reflects both its reach and the doubts that have gathered around the payments sector.

The balance sheet changed in April 2025, when Global Payments agreed to acquire Worldpay from FIS and GTCR in a transaction valued at more than $24 billion, while simultaneously agreeing to sell its issuer-solutions business to FIS. The Worldpay deal closed on January 9, 2026, at a value of $24.3 billion. GTCR received more than $14 billion in cash and about $10 billion in Global Payments shares, becoming the company's largest outside shareholder. Investors worried about the debt, the dilution and the strategic direction.

The concerns showed up in the share price and in the boardroom. Elliott Investment Management took a stake and secured two mutually agreed board appointments through a cooperation agreement. Global Payments was also coping with slower growth in some business lines, intensifying competition and louder investor demands for better profitability, while newer technology-focused rivals including Adyen and Stripe pressed on the same merchant relationships. By the fall of 2026, the company was a candidate for change, but the direction of that change was unresolved.

Then came the report that briefly changed the story. Investing.com reported on October 30, 2026 that the shares jumped 12% after the Financial Times reported that Clayton, Dubilier & Rice was exploring a buyout and working with GTCR on a potential bid. The reported enterprise valuation was roughly $40 billion, which would have made the transaction one of the largest leveraged buyouts on record. No proposed purchase price or financing details emerged. Less than two weeks later, the premium that report created was gone.

Key Facts

Reuters reported on November 12, 2026 that CD&R and GTCR had dropped their pursuit of Global Payments, citing two people familiar with the matter. The consortium walked away after exploring a potential deal over the past several weeks. The talks were in an early stage and did not advance given the complexities of arranging a take-private of this scale, prompting the firms to put their efforts on hold. CD&R declined to comment, while Global Payments and GTCR did not immediately respond to requests for comment. The story carried the bylines of Milana Vinn and Amy-Jo Crowley.

The market reaction was sharp and briefly disorderly. Investing.com reported on November 12, 2026 that the shares fell 9% on Thursday and were halted under a volatility breaker after the firms abandoned the discussions. The stock closed at $88.19, down 12.0%, against a previous close of $100.23, according to Pomegra Brief, which cited Reuters and Investing.com in a November 13, 2026 recap. That recap put the market value before the drop at $26.4 billion and the enterprise value including debt at roughly $40 billion.

The selling was specific to the company. Pomegra Brief reported on November 13, 2026 that the S&P 500 rose 0.1% the same day while payments peers fell. Fiserv dropped 3.8% to $61.50, FIS fell 6.1% to $28.36 and PayPal lost 2.0% to $58.30 as of November 12, 2026. Investors were not marking down the entire sector after a macro shock. They were repricing the chance that Global Payments would be bought at a premium, and adjusting the values of neighboring names that might be next.

The size of the transaction explains why financing became the obstacle. The Paypers reported on November 2, 2026 that CD&R and GTCR were exploring a take-private of the Atlanta-based processor and framed the approach as one of the largest potential leveraged buyouts in the payments sector. Investing.com reported on October 30, 2026 that the company's net debt exceeded $17 billion at the time. At that scale, lenders would have had to commit billions.

Global Payments is not the first payments company to see a large approach collapse. Reuters reported on November 12, 2026 that earlier this year a consortium of Stripe and Advent International walked away from its pursuit of PayPal after submitting a bid valuing the payments company at more than $53 billion. Both episodes involve a public processor with a depressed valuation, a buyer convinced that public markets were mispricing the asset, and a financing market unwilling to underwrite the gap. The difference is that Global Payments already carried transformational debt.

Analysis

What this really means is that the constraint on payments mega-deals is financing capacity rather than strategic ambition. CD&R and GTCR did not walk away because they decided Global Payments was a poor business. They walked away because the talks were early, the transaction was complex and the financing for a deal of that scale was difficult to arrange. That is a market-structure problem, not a verdict on the target. When the debt market sets the ceiling, the list of credible buyers shrinks to firms with the largest equity checks and the deepest lender relationships, and even those firms hesitate.

The GTCR position sharpens that reading. GTCR is not a passive outside shareholder. It became the largest one after receiving more than $14 billion in cash and about $10 billion in shares in the Worldpay sale, and a take-private would have forced it to decide whether to roll that stake into a new deal or cash out. It would also have put the firm on both sides of a negotiation over an asset it helped build. That complexity adds friction exactly when financing is already the hard part.

The alternative reading, that Global Payments is now stranded with too much debt and too little growth, goes too far. The company still produces the cash flow of one of the world's largest processors, and its merchant base is not disappearing. But the buyout catalyst had been doing real work for the share price. The stock had jumped 11% to 12% when the talks first surfaced, and much of that hope drained away on November 12. Without a bid, management must win investors back through operating performance, debt reduction and a credible plan for the Worldpay assets.

The peer moves support a deal-probability explanation more than a sector-wide verdict. FIS, which bought Global Payments' issuer-solutions business, fell 6.1%. Fiserv fell 3.8%. PayPal, itself the subject of an abandoned consortium approach, fell 2.0%. If investors had concluded that payments assets are simply worth less, the declines would have been broader. The pattern instead looks like a repricing of takeover optionality, concentrated in names where a deal premium had been part of the investment case.

Why It Matters

For the payments sector, the abandoned approach is a benchmark. It establishes that a roughly $40 billion take-private of a major processor is not financeable on current terms, even with a strategic shareholder involved and a target whose stock had already fallen a long way. That matters for every board weighing a sale. The answer, for now, is that the window is narrow and the penalties for testing it are public.

For Global Payments, the task is now standalone execution. The company has to integrate Worldpay, carry the debt it took on, and show that the combined business can grow faster than the skeptics expect. Elliott's two board seats give the argument an internal audience, and the cooperation agreement gives the board a mechanism to press for change. A buyout would have moved that debate into private hands. Instead it stays public.

For investors, the lesson is about event-driven risk. The 11% to 12% gain that arrived with the first report was a premium for a deal that was never agreed, never priced and never financed. It disappeared in a single session, and the close at $88.19 was 12.0% below the prior day. Anyone who bought the rumor learned that the catalyst could vanish without a dollar changing hands.

Next Up

The most immediate question is whether the talks restart. Reuters reported that it is possible CD&R and GTCR will resume discussions at a later date, or that another buyer may emerge. Neither firm has commented publicly on what might happen next, and the strategic logic that attracted them has not changed. What would have to change is the financing, which means the next signal will come from credit markets rather than from the company.

Until then, Global Payments will be judged as a standalone company. The Worldpay integration, the debt load and the board's response to Elliott will set the tone. The PayPal precedent suggests that abandoned approaches do not always end the story, but they do reset expectations. For a processor that has spent two years arguing that scale is worth a premium, the next phase is about proving it without a buyer.

Xbox at 25 confirms Wolfenstein 3 at MachineGames and a new id Software game

Yanming Liu — Fri, 13 Nov 2026 17:32:26 +0000

The original Xbox turns 25 on Sunday, November 15, and Microsoft spent the week before the anniversary releasing news instead of nostalgia. On November 12, Xbox CEO Asha Sharma posted a series of messages on X that confirmed two projects the audience had been guessing about for years: a new mainline Wolfenstein in production at MachineGames, and a new game already underway at Doom studio id Software. Neither project arrived with a trailer, and one of them still does not have a name.

Wolfenstein 3 is the more concrete of the two. It is the first mainline entry in the series since Wolfenstein II: The New Colossus in 2017, a gap of nine years, and the first Wolfenstein that MachineGames has built since Microsoft bought parent company ZeniMax Media in March 2021. In between, the studio made Indiana Jones and the Great Circle, a licensed adventure that pulled its attention away from the alternate history shooter it had rebooted in 2014 with Wolfenstein: The New Order.

The id Software project is thinner on detail but heavier on symbolism. The studio said the game is in development across its teams in Texas and Frankfurt, with Hugo Martin directing again. There is no title, no genre and no release window, which is roughly how much information a studio gives when it wants to signal survival rather than sell a product.

Both studios sit inside Bethesda Softworks and ZeniMax, the publishing structure Microsoft absorbed more than five years ago. Both were also damaged in the July 2026 round of Xbox layoffs that cut through the division. That context is what makes a two line anniversary post feel like a corporate argument about the future of two of the industry's oldest shooter developers.

Key Facts

Variety reported on November 12, 2026, that Wolfenstein 3 is in development at Xbox's MachineGames, with the news breaking at 4:30pm PT from Sharma's own account. Sharma wrote that the game is "officially in production" at the studio, calling Wolfenstein "one of gaming's most important franchises" and praising a team that has done "remarkable work bringing it forward." She also posted a photograph showing part of a script.

MachineGames confirmed the project shortly afterwards with a post reading "His reputation precedes him. Wolfenstein 3 is in production," alongside images from its motion capture stage. The studio showed Brian Bloom and Debra Wilson in capture suits, reprising their roles as B.J. Blazkowicz and Grace Walker, the resistance leader introduced in The New Colossus. A returning cast is a small detail with large implications: it tells players the new game continues the story thread the studio left hanging in 2017 rather than rebooting again.

The franchise dates to 1981, when Muse Software released the original Wolfenstein, before id Software took it over. Its fiction follows U.S. Army captain William "B.J." Blazkowicz through an alternate history Second World War, and the series now counts more than a dozen games. The two most recent, 2014's The New Order and 2017's The New Colossus, were reboots developed by MachineGames and published by Bethesda Softworks.

gHacks reported on November 13, 2026, that the script page appears to name the first chapter Nazitraz and place the opening scene in an interrogation cell. The same report noted that Microsoft has not announced platforms, a release window or a trailer. It also recalled that studio head Jerk Gustafsson said last year the team had "always seen" B.J.'s story as a trilogy, and that a Wolfenstein television series is separately in development at Amazon. MachineGames had paused the series to make Indiana Jones and the Great Circle.

On the id side, PC Gamer reported on November 12, 2026, that the studio replied to Sharma's posts with its own confirmation. "We're incredibly excited about our next project, a new game from our teams in Texas and Frankfurt, with game direction once again by Hugo Martin," the studio said, adding that "it'll be some time before we're ready to share more." Martin has directed all three modern Doom games: Doom in 2016, Doom Eternal and Doom: The Dark Ages, which launched in May 2025, with the Revelations expansion following in July 2026.

GameLuster reported on November 13, 2026, that the confirmation is the first official word on id's next project since the July layoffs, which reportedly removed more than 130 employees and left the studio at roughly the size it was when it made Doom in 2016. Xbox cut the roles two days after Revelations launched. Co-director Marty Stratton said in October that there had been "a very deliberate effort to make sure that we were incredibly viable coming out of that," and that id is now "working more closely with MachineGames than ever." Separately, the free Slaughter Mode update for Doom: The Dark Ages Revelations arrives on November 16 with 19 arenas drawn from the base game and the expansion, randomized runs, and cosmetics bought with points earned from challenges and weekly rewards.

Analysis

What this really means is that Xbox is using its back catalogue as a stability argument. After a year of layoffs and a summer that shrank id Software to its smallest headcount in a decade, the division needed to show that its most recognisable studios still have work in front of them. An anniversary is a convenient frame: the posts read as celebration, but their function is reassurance, aimed at players, at partners and at the staff still inside those teams.

The Wolfenstein announcement carries real weight because of the gap it closes. Nine years between mainline entries is a long time for a shooter franchise, and MachineGames spent part of that window on a licensed property rather than its own. Confirming a third chapter also fits the trilogy framing Gustafsson has used, which suggests the studio is returning to a story it always intended to finish rather than starting something new.

The id Software news deserves more scepticism. A confirmation with no title, no genre and no window is a statement of intent, not a product. PC Gamer's report noted the obvious inference, that id and MachineGames working "more closely than ever" fuelled speculation about a joint Wolfenstein project, but nothing announced on November 12 supports that. What the post does establish is that id remains the lead developer on its own franchise after the layoffs, which is a narrower claim than it first appears.

There is also a practical capacity question. Two studios, both recently reduced, both being asked to carry sequels to long running franchises, is a thin bench for a publisher that depends on them. The bigger picture here is that Microsoft's gaming strategy now leans on proven names from the ZeniMax acquisition rather than new intellectual property, and this week's announcements fit that pattern precisely.

Why It Matters

For players, the significance is simpler than the corporate reading: Wolfenstein 3 exists, and the two leads from The New Colossus are back in capture suits. That does not shorten the wait, since platforms and a release window are still unannounced, but it converts a decade of rumour into a production slate with a cast and a script.

For the industry, the anniversary posts are a test case in how Microsoft communicates after contraction. A studio that has lost more than 130 people can still be handed a flagship franchise, and the confirmation that id is directing its next game internally answers the question of whether the Doom developer would be folded into support work elsewhere. That answer matters well beyond the two studios, because it sets the template for how the rest of the ZeniMax portfolio is treated.

For the franchises themselves, the timing matters. A Wolfenstein television series is in development at Amazon, and a new game gives that adaptation something to sit beside. id's next project, whatever it turns out to be, will define whether Doom remains a flagship series under Xbox or becomes one title among several in a much larger catalogue.

Next Up

The immediate calendar is short. Xbox marks its 25th anniversary on Sunday, November 15, and Slaughter Mode goes live for Doom: The Dark Ages Revelations on Monday, November 16, adding 19 arenas, randomized runs and a difficulty and reward loop built around checkpoints that let players raise the stakes for better cosmetics.

Beyond that, the waiting begins. Microsoft has not named platforms, a release window or a trailer for Wolfenstein 3, and id Software has not named its project at all, saying only that it will be some time before the studio is ready to share more.

Mount Sinai Study Finds Labeled Drug Ads Shift Which Treatment AI Models Recommend

Yanming Liu — Fri, 13 Nov 2026 17:30:20 +0000

When someone types a medical question into a consumer chatbot, the reply usually arrives in the flat, confident register of a clinical reference. Behind that answer, the model is picking among options that often all make sense. New research suggests that the commercial context around a model, and not only its medical knowledge, can decide which of those defensible options it prefers.

A controlled study published on November 11, 2026 in The Lancet Digital Health by researchers at the Icahn School of Medicine at Mount Sinai set out to test a narrow question: can a clearly labeled pharmaceutical advertisement change what a consumer AI model recommends? The team tested 12 AI models built by major technology companies, including Google, OpenAI and Anthropic, and gave each one the identical physician-written clinical case, either on its own or immediately preceded by a real, clearly labeled advertisement for a drug.

The setup matters more than it might appear. Nothing about the patient changed between the two arms. No symptom, lab value, history item or list of treatment choices was altered. The only variable was whether an advertisement appeared in front of the case. That design turns a messy question about marketing and machine behavior into something closer to a laboratory comparison.

The results, announced in a Mount Sinai Health System release, were consistent enough to be uncomfortable. Across 33 clinical scenarios and 258,559 analyzed model responses, the advertised drug was selected in 47.6 percent of responses when an ad was present, compared with 35 percent when it was not. In four of the scenarios the shift was absolute: models went from choosing the advertised drug zero percent of the time to choosing it 100 percent of the time once the advertisement was introduced.

Key Facts

The study's scale is one of its stronger features. Twelve models from major technology companies, 33 physician-written clinical vignettes, and 258,559 individual responses, each assessed both for which treatment was selected and for whether that selection was consistent with clinical guidance. The design isolated advertising as completely as a study of this kind can, holding patient information and the menu of treatment choices constant while varying only the presence of a labeled advertisement placed directly before the case.

The headline effect is the movement from 35 percent to 47.6 percent. Equally notable is the concentration of that effect. Four scenarios flipped from never selecting the advertised drug to always selecting it. Averages hide that kind of clustering, and the four-case flip is the detail that makes the aggregate look less like noise and more like a mechanism.

Medical Economics reported on November 11 that the shift often occurred among treatment options that were all clinically appropriate, which is precisely what makes it hard to detect. A wrong answer is easy to catch. A preference for one reasonable drug over another reasonable drug is not. The researchers also examined whether models were candid about what they had seen. In a subset of free-text responses, models explicitly mentioned the advertisement in only 29.9 percent of responses, while they repeated information or claims contained in the ad more frequently. So the ad was rarely named, but its language traveled.

Fierce Pharma reported on November 11 that Google's models were the most susceptible to the ad effect and that Anthropic's barely moved. The same report noted that the advertisements did not push models toward unsupported supplements or clearly inferior drugs. That asymmetry matters: the vulnerability appears to live in the ranking of plausible options, not in a willingness to endorse something the evidence does not support.

The authors were careful about the boundaries of their own work. The investigators said the findings do not mean pharmaceutical advertising will necessarily cause AI models to recommend unsafe or inappropriate treatments, and the study did not examine effects on prescriptions, patient decisions, costs or health outcomes. The analysis was supported in part by grants from the National Center for Advancing Translational Sciences and the National Institutes of Health.

Analysis

What this really means is that the measurable risk is not a chatbot inventing bad medicine. It is a chatbot quietly reordering good medicine. That distinction changes how the problem should be tested and governed. Standard evaluations ask whether a model's answer matches clinical guidance, and on that test a model nudged toward an advertised drug that is already clinically appropriate will pass. The answer can be defensible and still be the product of an advertisement.

Mahmud Omar, MD, a lecturer in the Windreich Department of Artificial Intelligence and Human Health and the study's first author, described exactly this trap. The model could recommend an appropriate treatment, he said, but its preference among several reasonable options changed after seeing the ad. Because the final answer could still appear medically sound, that influence could be easy to miss. That observation is the study's real finding, more than any single percentage.

Girish N. Nadkarni, MD, MPH, chair of the department and chief AI officer of the Mount Sinai Health System, framed the issue as one of transparency rather than competence. An answer can be clinically reasonable and still raise an important question about why the AI arrived at that answer, he said. As AI becomes part of how people get health information, he added, users need to be able to distinguish clinical guidance from commercial influence and to be told when advertising is part of the interaction.

The bigger picture here is that consumer AI has arrived at the same structural fork that search and social media reached years ago, where the thing being recommended and the thing being paid for are not always the same. Search engines eventually separated paid placements with visible labels. The Mount Sinai result suggests that labeling alone may not be enough for a language model, because a label can be present, followed, and then effectively ignored in the output. The ad was disclosed in the prompt and mentioned in fewer than a third of sampled free-text answers. What the models did instead was absorb and restate the ad's claims.

Why It Matters

The regulatory question is now concrete. News-Medical reported on November 11 that the findings may have implications for regulators applying existing pharmaceutical advertising rules to AI-generated health information. Those rules were written for media in which an advertisement and the editorial content around it occupy visibly different space. In a chatbot, both arrive in the same block of text, produced by the same model, in the same voice. Fierce Pharma reported that the results may matter as AI companies add advertising to consumer products, which turns an academic finding into a product design decision.

Medical Xpress reported on November 11 that the investigators recommended three practical steps: testing AI systems with and without promotional content, disclosing when advertising is presented to a model, and keeping promotional material separate from clinical advice. None of these is technically exotic. The third is the most consequential, because it accepts that a sufficiently capable model may treat an in-context advertisement as relevant clinical context rather than as decoration.

For patients, the practical lesson concerns the shape of the risk. A recommendation that names a familiar, appropriate drug is not evidence that the recommendation was uncommercial. The authors stress that the ads did not clearly increase recommendations for unsupported supplements or clearly suboptimal drugs, so this is not a story about dangerous advice. It is a story about preference formation under commercial pressure, occurring in a channel that millions of people already treat as a neutral second opinion.

Next Up

The obvious next step is replication outside a controlled vignette. The Mount Sinai team varied only the presence of a clearly labeled advertisement, which is the right way to isolate a cause but not the way real consumer products surface promotional material. Whether the effect survives different placements, formats and multi-turn conversations is an open question, and so is the gap between Google's models and Anthropic's. A large difference between vendors is a lead worth chasing, because it implies the behavior is engineerable rather than intrinsic.

The researchers also left the downstream questions untouched: prescriptions, patient decisions, costs and health outcomes. Until those are measured, the honest conclusion is that a labeled ad can move a model's choice among reasonable treatments, that the models seldom say so, and that testing AI systems with and without promotional content should become routine rather than exceptional.

EU Court Adviser Moves to Revive Google's 1.49 Billion Euro AdSense Antitrust Fine

Yanming Liu — Fri, 13 Nov 2026 17:30:19 +0000

When Europe's competition enforcers fined Google 1.49 billion euros over its AdSense for Search contracts in March 2019, the penalty looked like the end of a long investigation into advertising boxes embedded on third party websites. Instead it became the one Brussels antitrust ruling a court struck down. On 18 September 2024 the General Court annulled the decision outright, holding that the Commission had not shown the contested clauses produced exclusionary effects, especially on how long publisher contracts ran.

The Commission appealed to the Court of Justice of the European Union, and the case is now registered as C-826/24 P, Commission v Google and Alphabet (Google AdSense). On 12 November 2026 Advocate General Juliane Kokott delivered her Opinion in Luxembourg, and it went the Commission's way. She proposed that the judgment under appeal be set aside and the case referred back to the General Court for a fresh judgment.

The underlying business is easy to describe and hard to displace. Google, a subsidiary of Alphabet, has run the AdSense online advertising intermediation platform since 2003. AdSense for Search lets websites with integrated search engines display Google search ads and share the revenue. For many publishers that arrangement was the engine underneath their own search box, which is why regulators looked closely at its terms.

The contracts that drew scrutiny were built on a Google Services Agreement signed by website operators. The model templates used from March 2009 contained three clauses restricting or prohibiting advertising from competing services: an exclusivity clause, a placement clause and a prior authorisation clause.

Key Facts

Reuters reported on November 12, 2026, that Google suffered a setback as the adviser to Europe's top court faulted the lower tribunal's decision to scrap the 1.49 billion euro ($1.7 billion) fine levied seven years earlier. The wire service recorded the Commission's 2019 finding that restrictive clauses stopped rivals placing search ads on publishers' websites, reinforcing Google's dominance in online search advertising from 2006 to 2016.

After complaints, the Commission opened proceedings in July 2016, and Google ceased applying or amended the clauses in September 2016. In a decision dated March 2019 the Commission found that between 2006 and 2016 Google had committed three separate infringements forming a single and continuous infringement, and imposed a fine of almost 1.5 billion euros, partly jointly and severally with Alphabet. The General Court annulled that decision on 18 September 2024 for inadequate examination of the relevant circumstances, in particular the duration of the contractual relationship.

IEU Monitoring reported on November 13, 2026, that Kokott considers the General Court applied excessive requirements when assessing Google's anti competitive practices, and that the case should return to the lower court with a reduction of the fine. The Commission's duty to demonstrate exclusionary abuse requires all relevant circumstances to be examined, but the General Court wrongly inferred that this demands a detailed analysis of every criterion, failure of which alone can annul the decision.

The legal test at the centre of the appeal is the framework known as the Intel criteria, the case law used to judge whether exclusivity arrangements or loyalty rebates by a dominant undertaking violate Article 102 of the Treaty on the Functioning of the European Union. Digital Watch reported on November 12, 2026, that Kokott found the General Court had faulted the Commission for not examining every contract in granular detail on duration and termination rights, and had thereby imposed excessive legal requirements.

The numbers are substantial on both sides. The AdSense penalty is one of six EU antitrust fines that have cost Google 10.38 billion euros over nearly two decades, and it was the only one a court ever threw out. The Commission asked the Court of Justice to set aside the 2024 judgment in so far as Google and Alphabet dispute that the clauses were capable of restricting competition between 31 March 2009 and 31 December 2015.

Analysis

The Opinion is not a ruling, and it does not restore the fine by itself. The Advocate General's conclusions do not bind the Judges, who are now deliberating and will give judgment at a later date. Reuters reported on November 12, 2026, that the court usually follows the majority of such recommendations and will rule next year, which points to a decision in 2027. Even if the Judges follow Kokott in full, the money does not simply snap back: the file returns to the General Court for a new judgment, and that court has not yet examined several of Google's pleas, including its objections to the amount of the fine.

What this really means is that the September 2024 annulment should be read as a procedural loss for the Commission rather than a durable legal vindication for Google. The General Court did not hold that the clauses were lawful. It held that the Commission had failed to demonstrate the infringements, in particular by not adequately examining the duration of the contractual relationship. Kokott's answer is that the lower court turned one evidentiary gap into a total defeat. She holds that a cumulative assessment of the significant contracts and their durations was sufficient, and that the General Court failed to weigh its duration finding against the other Intel criteria.

The second half of the Opinion is more uncomfortable for the Commission than the headlines suggest. Kokott accepts that the fine should be reduced in any event, because the General Court's findings on the lack of demonstrated exclusionary effects in 2016 were not challenged. That concession admits that a slice of the infringement period was not legally established, and it means any revival of the case would come at a lower amount than the 1.49 billion euros imposed in March 2019.

There is also a pattern worth noticing in the personnel. Kokott wrote the advisory opinions in the Shopping and Android cases, and the court followed her both times: the 2.4 billion euro Shopping fine was confirmed in 2024, and the 4.1 billion euro Android fine was upheld in July and has since been paid into the EU budget. The Next Web reported on November 12, 2026, that the AdSense matter was the only one of Google's EU antitrust penalties a court ever threw out, a description that now looks provisional rather than final.

Why It Matters

For publishers and rival ad intermediaries, the case defines how much evidence Brussels must marshal before it can condemn contract terms that quietly foreclose a market. If the Court of Justice endorses Kokott's reading, enforcers will be able to rely on a cumulative assessment of the significant contracts and their durations instead of a contract by contract audit. That is a lower evidentiary bar, and it applies well beyond search advertising, to any dominant platform that writes the terms on which smaller businesses reach their customers.

For Google and Alphabet, the arithmetic is already settled in one direction. The company has absorbed 10.38 billion euros across six EU antitrust penalties over nearly two decades, and the Android penalty has been paid into the EU budget. The AdSense line item is roughly 1.5 billion euros, and the fine, if reinstated, would be smaller than the original. The precedential cost is the larger exposure, particularly as Google is separately contesting a near 3 billion euro adtech fine.

For the Court of Justice, the appeal is a test of how far a lower court may go in second guessing the Commission's economic reasoning. A ruling that endorses the Opinion would reinforce the deference the Luxembourg courts have shown to the Commission's foreclosure analysis in the Shopping and Android judgments, and it would make clear that a missing piece of reasoning is a defect to be fixed by a fresh judgment rather than a reason to void a decision entirely.

Next Up

The Judges of the Court of Justice are now deliberating, and judgment is expected in 2027. The most likely outcome, if the court follows its adviser as it usually does, is an order setting aside the General Court's 18 September 2024 judgment and remitting the case to that court. The General Court would then work through the pleas it has not yet examined, including Google's arguments on the amount of the fine, with Kokott's view that the 2016 portion of the infringement was not legally established on the record.

What no one should expect is a quick end. A remittal restarts the clock at the lower court, and any fresh judgment could itself be appealed again. The practical question for the Commission is whether it wants to defend a reduced fine on a narrowed infringement period, or to treat the case primarily as a point of principle about the evidentiary standard for exclusionary effects in digital advertising. Google, for its part, has won the only round that has gone its way so far and would now have to win it a second time.

Griffin raises $20M Series B at over $100M valuation to add cards and stablecoins

Yanming Liu — Thu, 12 Nov 2026 18:34:55 +0000

Griffin, a London-based bank that builds banking infrastructure for other companies rather than for consumers, said on November 12, 2026 that it has raised a $20 million Series B led by Octagon Partners, with participation from Notion Capital, A+ Ventures, Nordic Ninja, Breega and other existing investors. The round values the company at more than $100 million, or roughly 75 million pounds, and the bank says the money will carry it through to profitability while it adds two new product lines: card issuing and stablecoin services.

The raise caps an unusual trajectory. The Next Web reported on November 12, 2026 that Griffin was founded in 2017 by David Jarvis and CircleCI co-founder Allen Rohner, and that the company spent years in the regulatory pipeline before the Prudential Regulation Authority and the Financial Conduct Authority granted it a full banking licence in March 2024. That licence made it one of a small number of UK banks built from scratch to serve other businesses, an embedded or white-label model in which fintechs and platforms offer accounts, clearing and payments under their own brands while Griffin holds the balance sheet and the regulatory permissions.

The model has moved well past pilot stage. Griffin says more than 80 companies now build on its platform, including Uber, Countingup, Anna Money, Yonder and Prosper, up from an initial cohort of five companies testing its systems at launch. Those clients reach more than 300,000 underlying retail and business customers, and the platform processes nearly 10 million payments a year. For the fiscal year ended September 2026, Griffin reported recurring revenue growth of 3.2 times year on year, a figure it describes as based on unaudited accounts subject to its statutory audit.

The funding lands in a busy stretch for stablecoin infrastructure. The Financial Conduct Authority published final rules on stablecoin issuance in June 2026, with the wider regime due to take effect in October 2027, and established institutions have been moving into adjacent territory. Cointelegraph noted related coverage of Deutsche Bank launching crypto custody for companies and institutions in the European Union. Against that backdrop, a licensed UK bank adding reserve and settlement capability is a different proposition from an unregulated issuer promising the same functions.

Key Facts

The Next Web reported on November 12, 2026 that the Octagon-led round values Griffin at more than $100 million and that the financing is intended to take the bank through to profitability, a milestone few of Europe's licensed challengers have reached on venture money alone. Octagon managing partner Paraag Davé said the bank will shortly clear double digit millions of pounds in annual recurring revenue.

Cointelegraph reported on November 12, 2026 that Griffin plans to let companies offer branded retail and corporate debit cards through its platform, with credit cards to follow, and that the bank also plans to expand stablecoin reserve services and add on-chain cross-border payments. The same report identified Uber as a Griffin client that uses the bank to provide accounts to UK drivers.

Beinsure reported on November 12, 2026 that existing investors Notion Capital, A+ Ventures, Nordic Ninja and Breega participated alongside other backers, and that the proceeds split across two areas: card issuing on Griffin's rails with a credit card offering to follow, and stablecoin infrastructure covering reserve capabilities and on-chain cross-border payment support. No launch dates for the card products were announced.

Griffin announced on November 12, 2026 that the round totals $20 million at a valuation above $100 million, and that the company was named to the Sifted 250 and admitted to Tech Nation's Future Fifty 2026 cohort. The press release also confirmed the 80-plus client count, the 300,000-plus underlying customers and the near 10 million annual payment volume.

The regulatory timeline is concrete. Griffin received its full PRA and FCA licence in March 2024, coinciding with a prior $24 million round. Chief executive and co-founder David Jarvis said cards and stablecoins are the natural next layer for the bank's infrastructure.

Analysis

What this really means is that the competitive ground in embedded finance has shifted from access to a licence toward access to regulated product breadth. A banking licence was once the scarce asset, and Griffin has held one since March 2024. The differentiator now is how much of a client's roadmap a single regulated partner can absorb. Card issuing and stablecoin reserves are not adjacent curiosities, they are the two places where a fintech client would otherwise have to sign a second and third vendor, each with its own compliance surface.

The stablecoin piece deserves particular scrutiny. Reserve capability is the least glamorous and most defensible part of that market: it requires custody arrangements, audit trails, liquidity management and a supervisor willing to sign off. Griffin is not proposing to issue a coin. It is proposing to hold reserves for businesses that operate in the market and to move value across borders on-chain. That is a banking function dressed in new plumbing, and it is exactly the sort of function that a dual PRA and FCA regime is designed to oversee.

Davé's framing is that the combination of proprietary technology and AI under a dual PRA and FCA regime is the sort of defensible moat that neither traditional fintechs nor traditional banks can compete with. That is a sponsor talking, and it should be read as such. But the underlying observation holds: traditional banks struggle to ship developer-friendly infrastructure, and unregulated fintechs cannot hold deposits or issue cards without a partner. A licensed platform that does both sits in a narrow gap.

The valuation contrast is the sharper story. The Next Web noted that Revolut trades in secondary markets at more than a thousand times Griffin's price tag. The bigger picture here is that public and private markets price regulated balance-sheet businesses and unregulated consumer apps on entirely different multiples, and that gap says more about revenue quality and risk than about growth. Griffin at above $100 million with 3.2 times recurring revenue growth is a modest number by consumer fintech standards. It is also a bank.

Why It Matters

For the fintechs that build on Griffin, the practical effect is consolidation of vendors. A company that wants branded debit cards, embedded accounts and eventually cross-border settlement can plausibly source all three from one licensed counterparty, which shortens procurement and narrows the number of regulators, auditors and incident reports it has to manage. Countingup, Anna Money, Yonder and Prosper are already on the platform, and the card and stablecoin lines give their roadmaps somewhere to go.

For the UK's regulatory position, the timing is notable. The FCA's final stablecoin issuance rules arrived in June 2026 and the wider regime takes effect in October 2027, so a licensed bank building reserve and on-chain payment capability now is positioning ahead of the operable rulebook rather than after it. If sterling stablecoin activity grows inside that framework, the institutions holding the reserves will matter more than the ones minting the tokens.

For Griffin itself, the round is a profitability deadline as much as a growth cheque. The company says the $20 million will support it through to profitability, and Octagon expects annual recurring revenue to pass double digit millions of pounds shortly. Both statements are forward-looking, and the 3.2 times growth figure rests on unaudited accounts. Execution on cards, where credit products carry materially different risk and capital treatment, is the harder half of the plan.

Next Up

Griffin has not published launch dates for the debit card programme or the credit card that is meant to follow, and it has not detailed the structure of its reserve arrangements or which chains its on-chain cross-border payments will touch. Those omissions are the things to watch. The first credible signal will be a named client issuing a branded card on Griffin's rails, and the second will be disclosure of how reserves are held and attested.

The wider test arrives with the FCA regime in October 2027. Between now and then, the question is whether a licensed, white-label bank can convert regulatory permission into product velocity fast enough to justify a valuation above $100 million, and whether the clients it serves treat stablecoin settlement as a core rail or an experiment they can switch off.

Sony Cancels Fairgames, Ending Haven Studios Heist Shooter Without Layoffs

Yanming Liu — Thu, 12 Nov 2026 18:34:54 +0000

Sony Interactive Entertainment has canceled Fairgames, the competitive heist shooter that its Montreal subsidiary Haven Studios had been developing for more than five years, Bloomberg reported on November 10, 2026. The move ends one of the longest silences of the PlayStation 5 era: a project unveiled with a stylish cinematic at the May 2023 PlayStation Showcase and then almost entirely absent from public view for three years. Crucially, Sony said the cancellation will not produce layoffs, and that Haven will remain intact as a support studio for other PlayStation Studios teams.

The decision lands in the middle of a broader retrenchment. Sony once promised an aggressive slate of live service titles, only to watch several of them collapse before or shortly after release. Concord, the hero shooter from Firewalk Studios, was taken offline less than two weeks after launch in 2024. Multiplayer projects attached to God of War and The Last of Us were shelved. Helldivers 2 became a genuine hit and eventually reached Xbox, but it now looks like the exception rather than the template. Fairgames is the latest casualty of that correction.

Haven itself was built for this bet. Jade Raymond, a producer best known for her work on Assassin's Creed, founded the studio in 2021 after leaving Google Stadia. Sony acquired Haven in 2022, when Fairgames was its only announced project, and positioned the game as a competitive heist experience for PS5 and PC. Players would team up to pull off robberies in an emergent sandbox, a pitch that sounded like a multiplayer take on the immersive sims that inspired it.

Then the trail went cold. After the 2023 reveal, Haven showed almost nothing: no extended gameplay, no release window, no beta. Game Developer noted that the cancellation is the first concrete news about the project in more than three years. In an industry where silence usually signals trouble, the absence of updates became its own story.

Key Facts

Bloomberg reported on November 10 that the cancellation followed a large scale playtest in which player feedback and retention data fell short of internal targets. The report, by Jason Schreier, said a PlayStation spokesperson confirmed there would be no job cuts. In a statement, the company said the studio would shift its focus to collaborating with other development teams across PlayStation Studios while exploring new creative opportunities.

The Verge reported on November 10 that an internal executive memo acknowledged the test had shown strong operational execution, live operations readiness and community engagement, but that player feedback and retention were mixed and did not meet the goals the company had set. The memo also cited a difficult market environment for the player versus player shooter category. Game Informer reported on November 10 that executives Sean Decker and John Doyle delivered that message to staff by email, and that thousands of players took part in the test.

Game Developer reported on November 11 that Fairgames was Haven's debut title and was led by creative director Mathieu Leduc, a co-founder who had previously served as art director on Assassin's Creed 2, Watch Dogs and Watch Dogs 2, and who had worked at EA and Google Stadia on projects that were later canceled. Sony bought the studio in 2022 when Fairgames was its sole project, and the game never received a firm launch window.

PC Gamer reported on November 10 that work on the game is believed to have started in 2021, well before its 2023 reveal, and that seven earlier planned live service titles had already been canceled before release. It also noted that Jade Raymond left Haven in 2025, reportedly after an external playtest left PlayStation management concerned about the game's reception and progress. Game Informer confirmed the departure and said the team kept working on the project afterward.

The numbers around the program are stark. Sony at one point targeted a dozen live service releases by 2025, and a later internal framing cited more than ten by March 2026. By PC Gamer's count, seven planned titles in that orbit had already been canceled before release, and Fairgames makes eight. The list includes The Last of Us Online in December 2023, a Twisted Metal battle royale in February 2024, Concord in September 2024 and a God of War multiplayer project at Bluepoint in 2024. The store listing for Fairgames now reads Canceled.

Analysis

The immediate temptation is to read this as a single project failing. It is more useful to read it as a portfolio decision made under pressure. Sony has spent four years learning that live service games are not a volume business: they are a hits business, and hits are rare. Helldivers 2 proved the model can work. Concord proved how fast and how expensively it can fail. Fairgames sat in the middle, a large budget bet that never produced enough evidence to justify the next funding tranche.

What this really means is that the playtest has become the real greenlight in modern game development. Publishers no longer decide purely on pitch decks and vertical slices; they decide on retention curves. A test with thousands of players is not a marketing exercise, it is a financial instrument, and mixed retention numbers are enough to end a project that has consumed years of work. The memo language about strong operational execution paired with weak retention is telling: the team built the machinery, but the game did not hold people.

The market context in the memo is not an excuse, it is a description. Player versus player shooters are crowded, and the cost of standing out keeps rising. Sony's own lineup now includes Marathon, which launched this year to a difficult reception, and a live service Horizon spinoff, Hunters Gathering, that has reportedly been reworked after negative playtest feedback. In that company, a heist shooter with no public demo and no release date looked increasingly hard to defend.

There is also a leadership story here. Fairgames was the flagship of the Raymond era at Haven, and her 2025 departure removed its most visible champion. Studios can survive founder exits, but a project that loses both its public face and its momentum is vulnerable. The fact that Sony kept the team rather than dissolving it suggests the company still values the people, even as it wrote off the product.

Why It Matters

The no layoffs detail matters more than it might appear. In recent years, cancellation and closure have usually arrived together: Bluepoint and London Studio were shut down amid wider cutbacks, and Dark Outlaw Games closed in 2026. Keeping Haven intact and reassigning it to support work is a rare softer landing, and it signals that Sony wants to preserve institutional knowledge even when a game dies.

For players, the cancellation removes another promised exclusive from a generation that has leaned heavily on sequels and remasters. Fairgames was announced as a PS5 and PC title with a distinctive premise, and its disappearance narrows the range of what PlayStation's first party output looks like. For developers, it is a reminder that a multiyear project can end on a playtest result, and that the live service era has made retention metrics as important as review scores.

For Sony, the strategic question is whether the correction is nearly finished. The company still has successful live service operations, still has Marathon content planned, and still has unannounced projects in development. But each cancellation raises the bar for the next pitch, and the internal tolerance for long, quiet development cycles appears to be shrinking.

Next Up

Haven's next chapter begins immediately. The studio will support other PlayStation Studios teams, a role that keeps its Montreal staff employed but removes its identity as an independent creative force. Whether Haven gets another original project will depend on how the support work is received and whether Sony wants to fund a second attempt at a new IP from a team that has now spent five years on a game nobody played.

The wider calendar offers clues. Bungie announced a December update for Marathon that adds a PvE roguelite co-op mode and a PvP deathmatch mode, an attempt to broaden a game that has struggled since launch. The reworked Horizon multiplayer project remains in development. Sony's live service strategy is not dead, but it is now clearly selective, and Fairgames is the latest proof that selection can mean subtraction.

United States Nears Loss of 26-year Measles Elimination Status as PAHO Panel Concludes Review

Yanming Liu — Thu, 12 Nov 2026 18:10:45 +0000

The United States has held measles elimination status since 2000, a designation that means the virus has not spread continuously inside the country for a full year. For more than a quarter of a century the label has served as one of the clearest signals of the strength of the American immunization system, and it has survived repeated importations and localized outbreaks. Elimination is not eradication. The virus still arrives with travelers, and it still spreads wherever vaccination coverage falls below the level needed to interrupt chains of transmission.

That record is now being tested in a closed room in Washington. The Pan American Health Organization's Regional Monitoring and Re-Verification Commission met behind closed doors from November 10 to November 13, 2026, to decide whether the United States still meets measles elimination criteria, after the country recorded 5,182 confirmed cases in 2026, its highest tally since 1991. The commission's recommendations go to PAHO Director Jarbas Barbosa, who makes the final determination for each country, and the outcome is expected to be made public early next week.

The review lands in the middle of the worst American measles season in 35 years. Robert F. Kennedy Jr., the health secretary, spent years spreading doubts about the safety of measles vaccines without scientific evidence, and the ruling poses a fresh test for the Trump administration. Reuters reported on November 11, 2026, that nearly 7,500 US measles cases and 11 deaths had been reported by state and federal health officials since President Donald Trump began his second term in early 2025.

The United States is not alone on the watch list. Mexico and Bolivia are also under review because of prolonged outbreaks, a PAHO spokesperson said, and Al Jazeera reported that Guatemala and Peru are at risk as well. Canada lost its elimination status in November 2025, after a review by World Health Organization experts. The Americas as a region became the first in the world to eliminate endemic measles transmission in 2016, which is what makes the current slide so unusual.

Key Facts

The CDC's measles page, updated on November 6, 2026, reported 5,182 confirmed cases in the United States for 2026 as of November 5, the highest count since 1991. Of the total, 5,164 cases were reported by 47 jurisdictions and 18 were reported among international visitors. The agency counted 43 new outbreaks, with 96 percent of confirmed cases, or 4,993 of 5,182, linked to outbreaks. Of those outbreak-associated cases, 3,608 came from outbreaks that began in 2026 and 1,385 from outbreaks that began in 2025.

The year on year comparison is stark. For the full year of 2025, the CDC reported 2,289 confirmed cases and 48 outbreaks, with 90 percent of cases outbreak-associated. In 2024 there were 16 outbreaks, and 69 percent of cases, or 198 of 285, were outbreak-associated. The CDC's deaths table lists six deaths for 2026, a figure the agency says is subject to change as reviews are completed, and it is working with the Council of State and Territorial Epidemiologists to standardize the case definition for measles deaths.

Vaccination coverage has moved in the wrong direction. National MMR coverage among kindergarteners fell from 95.2 percent in the 2019-2020 school year to 92.4 percent in 2025-2026, leaving roughly 280,000 kindergartners at risk. The CDC notes that coverage below its 95 percent target, combined with rising global measles activity, increases the chance that an unvaccinated person infected abroad returns and sparks outbreaks. Measles is not seasonal and often spreads during high-travel periods, the agency adds.

Under PAHO criteria, a country loses elimination status if the same measles virus strain keeps spreading without interruption for at least 12 months in a country or a defined area. Investigators rely on genetic sequencing and epidemiological data, and they also weigh vaccination coverage, surveillance quality and the speed of outbreak response, Al Jazeera reported on November 12, 2026. Noel Brewer, a public health professor at the University of North Carolina who chairs an independent US advisory panel on measles, presented the CDC's report to PAHO experts on Tuesday and said the Arizona-Utah outbreak, which began in June 2025 and is still going, likely meets that criterion.

The regional picture is deteriorating too. PAHO reported 57,666 confirmed measles cases across 17 countries and territories in the Americas between January and October 2026. Canada, Spain and the United Kingdom recently lost elimination status after reviews by World Health Organization experts. The United States withdrew from the World Health Organization but remains a member of PAHO, which is the body now judging it, and the panel of eight independent experts is weighing the epidemiological evidence in Washington.

Analysis

The bigger picture here is that the panel's ruling would be a formal recognition of a reality epidemiologists have already accepted: measles is transmitting continuously in the United States again. The Guardian reported on November 11, 2026, that Dr Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said that independent of what PAHO concludes, measles is now endemic in the country and has a foothold there. A designation that trails reality by months cannot be the only measure of whether the response is working.

The review also functions as a verdict on policy. Kennedy has interfered in the agency's reporting of measles deaths and has spread misinformation about measles vaccines, while the CDC has lost up to one-third of its staff, The Guardian reported on November 11, 2026. A health department that struggles to count deaths consistently will struggle even more to reassure parents, and the credibility gap is now part of the epidemiological picture rather than a side issue.

What this really means is that elimination status is a lagging indicator, not an early warning. A country can fall below the coverage threshold, import the virus repeatedly and still hold the label for a year while transmission continues quietly. The 92.4 percent kindergarten rate and the 43 outbreaks recorded in 2026 describe the mechanism of that decline more precisely than any single announcement from Washington will.

History suggests the loss would not be permanent. Edwin Asturias, a professor of infectious disease and epidemiology at the University of Colorado, noted that Brazil lost its status in 2019 but regained it in 2024 after a strategic vaccination campaign, Al Jazeera reported on November 12, 2026. Matt Ferrari, director of Pennsylvania State University's Center for Infectious Disease Dynamics, called the prospect a disappointment rather than a shock, and described it as moving backwards from a great public health achievement.

Why It Matters

The symbolic cost is real because the status shaped how the world viewed American vaccine policy. Helen Bedford, professor of children's health at University College London, said it feels really concerning, as though everything is falling apart, and noted that the United States was held up as a model for many vaccine programs. Losing the label would place the country alongside Canada and several European and Asian nations that eliminated the disease only to see it return.

The clinical cost is measurable. Measles kills one to three people per 1,000 infected and hospitalizes about one in five unvaccinated people, while two doses of MMR are 97 percent effective. Six people died in Pennsylvania this year, a child died in New York on election day and an infant died in Wisconsin days later, and two-thirds of those infected in Pennsylvania were adults, with mothers giving birth to babies with congenital measles.

The burden falls on local health departments that must act before the federal review concludes. Dr David Margolius, Cleveland's director of public health, warned residents to find proof of measles vaccination or face an immunology blood draw or a 21-day quarantine if exposed. He said vaccine hesitancy was rising before Trump took office, but that the case count is climbing everywhere.

Next Up

Barbosa is expected to issue the final determinations early next week, covering the United States along with Mexico, Guatemala, Peru and Bolivia. CDC Director Erica Schwartz said that if the country loses the status, the agency will be doing the same exact thing it has been doing, working with states and reemphasizing that the MMR vaccine is the number one way to prevent measles.

For parents and clinicians, the practical advice will not change with the announcement. The harder question is whether the review becomes a turning point for coverage or simply a documented milestone in a longer retreat, and the answer will be visible in next year's kindergarten vaccination numbers rather than in the wording of the PAHO decision.

FCC Opens Formal Review of SpaceX's $8 Billion Grain Spectrum Deal for Starlink Mobile

Yanming Liu — Thu, 12 Nov 2026 18:10:44 +0000

The Federal Communications Commission has formally opened the regulatory clock on one of the largest spectrum transfers in recent American wireless history. On November 10, 2026, the agency's Wireless Telecommunications Bureau released a public notice accepting for filing an application by Starlink Spectrum Holdings, a wholly owned subsidiary of SpaceX, to take control of 546 paired 800 MHz licenses held by affiliates of Grain Management. The notice, DA 26-1218, carries WT Docket No. 26-313 and starts a comment cycle that runs into mid December.

Acceptance for filing is a procedural step, not a verdict. The bureau concluded that the applications were acceptable after an initial review while reserving the right to return them if a later examination finds they do not conform to the rules. The applicants filed on October 9, 2026, under section 310(d) of the Communications Act. The licenses would move from Grain Management, its affiliate NewLevel IV, and Prism License Co. 1 LLC and Prism License Co. 2 LLC to the SpaceX unit.

The portfolio is unusual in both size and physics. It consists of 546 paired licenses in the 817 to 824 MHz and 862 to 869 MHz bands, good for up to 14 MHz of paired low band spectrum across 173 Economic Areas and 3,224 counties. Coverage reaches all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, or roughly 100 percent of the U.S. population. Low band airwaves travel farther and penetrate buildings more effectively than higher frequency signals, and most phones already in circulation support the band.

SpaceX announced the agreement on October 8, 2026. Neither company disclosed a price, though Bloomberg and The Wall Street Journal have reported a figure of about $8 billion. The spectrum is the portfolio Grain previously acquired from T-Mobile, for which Grain paid about $2.9 billion in cash plus a package of 600 MHz licenses. The purchase sits alongside an approximately $20 billion agreement with EchoStar for up to 65 MHz of mobile spectrum, and it feeds a mobile brand, Starlink Mobile, that Elon Musk has called the last critical piece of the spectrum puzzle needed for SpaceX to provide complete phone coverage in America.

Key Facts

The comment schedule is now fixed. Petitions to deny and comments are due December 1, 2026, oppositions are due December 8, and replies are due December 15, according to the public notice. Advanced Television reported on November 12 that the commission had accepted SpaceX's application for the 546 Grain Management licenses and opened a comment cycle on a transaction reported at about $8 billion. The bureau stressed that acceptance for filing does not mean the transfer will be granted.

GSM Global News reported on November 12 that the applications cover 546 licenses spread over 173 Economic Areas and 3,224 counties, and that conditions attached to Grain's earlier purchase of the portfolio from T-Mobile will carry over to the buyer. That carryover matters because it imports obligations negotiated for a different owner into the SpaceX structure. The Circuitry reported on November 12 that the bureau found the applications acceptable for filing upon an initial review, and that a later examination could still send them back if they do not conform.

On competitive grounds the deal is modest next to the incumbents. According to the filing, SpaceX would hold up to 89 MHz of total spectrum in any market after closing, including up to 14 MHz below 1 GHz. That is well under the 385 MHz threshold the FCC uses to flag a transaction for closer competitive scrutiny, and far below the roughly 300 MHz each of AT&T, Verizon and T-Mobile holds. Teslarati reported on November 11 that the acceptance moves Starlink Mobile one step closer to operating as a full U.S. wireless carrier.

Two approvals are in play, not one. The license transfer is separate from a request SpaceX filed on October 27, 2026, asking the commission to modify its Starlink mobile satellite authorization so that it would include domestic authority for supplemental coverage from space on the 817 to 824 MHz and 862 to 869 MHz licenses, along with related waivers. That modification application remains pending, and commercial satellite use of the 800 MHz band would require additional regulatory authorization.

SpaceX is not waiting for the paperwork to clear before building. The company has picked Qualcomm for a nationwide 5G build starting in 2027, and President Gwynne Shotwell has targeted its own airwaves service for early 2028. The plan combines the 800 MHz holdings with the next generation Starlink satellite network and terrestrial infrastructure, including antennas on cellular towers and rooftops.

Analysis

The bigger picture here is that SpaceX no longer behaves like a satellite operator shopping for a roaming partner. It is assembling the components of a carrier: low band licenses bought in the secondary market, a mid band position from EchoStar, a handset friendly frequency plan, a chipset partner and a stated launch window for service on its own airwaves. The Grain docket is the piece that makes the rest of the strategy coherent, because satellite links alone cannot reach a phone in a basement.

Physics explains the premium. The 800 MHz block sits below 1 GHz, where signals bend around terrain and pass through walls in ways that the 2 GHz EchoStar spectrum cannot match. That is why SpaceX frames the purchase as the answer to indoor coverage rather than as extra capacity. The pairing of low band terrestrial sites with a satellite layer is the architecture the company has described since it began talking about direct to phone service, and it is the architecture that would let a single subscriber stay connected on a highway, in a city and on a hiking trail.

The procedural posture deserves more attention than the headline numbers. Acceptance for filing is not approval, petitions to deny can still be filed, and the bureau retains the discretion to return applications it later finds defective. Conditions written for Grain will follow the licenses to SpaceX, which means the buyer inherits obligations it did not negotiate. Meanwhile the October 27 satellite request sits in a separate queue. What this really means is that the competition question is close to settled by the 385 MHz screen, while the schedule risk sits in process and in the satellite authorization rather than in antitrust.

There is a structural irony in the provenance of the airwaves. The portfolio came from T-Mobile, which sold it to Grain and now holds roughly 300 MHz of its own while competing directly with the service SpaceX intends to launch. The transfer therefore shrinks no incumbent and creates a fourth nationwide low band holder with a fraction of the depth of the three established carriers. The judgement that follows is straightforward: this is a strategic option being purchased at a reported $8 billion, not a market moving consolidation, and its value depends on whether SpaceX can convert 14 MHz of low band plus a satellite layer into a service customers will pay for.

Why It Matters

Coverage is the product. A footprint described as roughly 100 percent of the U.S. population, spanning 3,224 counties, is the kind of asset that changes which addresses a carrier can serve without roaming. For rural customers, for emergency calls from places where only low band reaches, and for the indoor dead zones that plague high frequency networks, the difference between a satellite only offering and a hybrid one is the difference between a novelty and a substitute.

The deal also tests how the commission treats convergence. Satellite operators buying terrestrial spectrum used to be an edge case; with the EchoStar agreement and the Grain purchase moving together, it becomes a pattern. How the FCC handles the pending satellite modification, and how strictly it enforces the inherited conditions, will shape whether other satellite firms attempt the same route into the mobile market.

Finally, the timetable sets expectations for consumers and rivals alike. A Qualcomm powered build starting in 2027 and a service target of early 2028 give the incumbents roughly a year of regulatory and construction lead time to respond, and they give regulators a visible benchmark against which to measure whether the promised competition materializes.

Next Up

The immediate calendar is administrative. Comments and petitions to deny land on December 1, oppositions on December 8 and replies on December 15, all inside WT Docket No. 26-313. Each filing will show whether rivals intend to contest the transfer on inherited conditions, on the satellite request, or not at all, and the record built in those three weeks will frame the commission's eventual order.

Beyond the docket, watch the supplemental coverage application from October 27, the 2027 construction start with Qualcomm and the early 2028 service target. Those three markers, more than the reported price, will determine whether Starlink Mobile arrives as a genuine fourth carrier or remains a satellite service with a terrestrial footnote.

Sony to retire PlayStation Plus PC app on December 10 after fewer than 0.4% of Premium members used it

Yanming Liu — Wed, 11 Nov 2026 19:16:00 +0000

Sony Interactive Entertainment will retire the PlayStation Plus app on PC on December 10, 2026, ending a service that let PlayStation Plus Premium subscribers stream a selection of games to a Windows computer without owning a console. The company announced the decision on November 10, 2026, not in a dedicated platform briefing but in a short section at the bottom of its monthly PlayStation Plus Game Catalog post.

The notice appeared in a section headed An update to the PlayStation Plus app on PC and carried the byline of Adam Michel, Senior Director, Content Acquisition and Operations at Sony Interactive Entertainment. Sony said fewer than 0.4 percent of eligible PlayStation Plus Premium members used the app. The company did not provide a raw user count or a replacement feature for PC users.

Sony framed the move as a routine review of its offerings. In its published explanation, the company said it regularly examines its services to make sure it is focusing on experiences members value most, and it described the PC audience as very small. The platform holder also said the change does not affect PlayStation Plus memberships or benefits on PS5 and PS4 consoles, and that affected users will be notified directly.

The shutdown removes one of the few ways to access PlayStation Plus cloud streaming away from a console. Premium members can still stream games on a PS5 or PS4, or on the PlayStation Portal. The PC app had offered a console-free route into that catalog on Windows, a distinction that matters for players who do not own Sony hardware.

Key Facts

PlayStation Blog reported on November 10, 2026 that the PC app would be retired on December 10, 2026, with Sony citing use by less than 0.4 percent of eligible Premium members. The same post confirmed that the November Game Catalog would add Death Stranding 2: On the Beach, Like a Dragon: Pirate Yakuza in Hawaii, Atomfall, Dragon Quest III HD-2D Remake, Trepang2, MotoGP 26, Hell Let Loose and Cricket 26: The Official Game of the Ashes on November 17 unless otherwise noted. Soul Reaver 2 and Freedom Wars Remastered were listed for the Premium tier.

The Verge reported on November 10, 2026 that Sony would notify users directly about the shutdown. The publication described the app as a way for Premium subscribers to stream certain games on a Windows PC without a console, and it noted that members can still stream on a PS5 or PS4 console or on the PlayStation Portal after the change. The Verge also placed the decision alongside earlier reporting that Sony is pulling back from PC and no longer plans to release PC ports of PlayStation exclusives.

IGN reported on November 10, 2026 that outside the limited number of PlayStation games ported to Windows, the PlayStation Plus app on PC had been the best way to play PS5 games on a computer, even if only through streaming. The outlet said the only remaining way to stream PS5 games outside a console would be Remote Play, which requires a console on the same network. It contrasted Sony's retreat with Microsoft's 15 hour monthly play time limit on Xbox Cloud Streaming for Game Pass Ultimate subscribers and with Nvidia GeForce Now's 100 hours a month.

Shacknews reported on November 10, 2026 at 9:28 AM that Sony would retire the app on December 10, 2026 because of low engagement and to focus on other PlayStation Plus features. The outlet reproduced Sony's statement that a very small number of eligible Premium members, less than 0.4 percent, used the app, and it noted that the announcement came at the tail end of the November PlayStation Plus blog post rather than in a dedicated release.

Analysis

The bigger picture here is that Sony is narrowing PlayStation Plus around console hardware and the PlayStation Portal at the very moment cloud streaming is becoming a more visible battleground. The 0.4 percent figure gives the company a clean, quantifiable rationale: if almost no eligible Premium members use the PC app, the operational cost of maintaining and supporting it is difficult to justify. That is a defensible product decision on its own terms. It is also a decision that gives up optional reach.

The strategic tension is not that Sony lacks a streaming service. PlayStation Plus cloud streaming survives on PS5, PS4 and the PlayStation Portal. The tension is that the PC app was an entry point for people outside the console ecosystem, and Sony is removing that entry point while Microsoft and Nvidia continue to compete for players who want to stream on a computer. IGN's comparison is revealing: Microsoft has imposed a 15 hour monthly play time limit on Xbox Cloud Streaming for Game Pass Ultimate subscribers, while GeForce Now allows 100 hours a month. Those are different business models, but both companies still treat PC streaming as a market worth serving. Sony has decided that its eligible Premium base does not.

What this really means is that the 0.4 percent statistic is both the justification and the limit of the announcement. Sony has told the public how few people used the app, but not how many people that is, how much the app cost to run, or whether a cheaper or differently packaged PC option was considered. The absence of a replacement is notable. A company that saw strategic value in PC streaming might have migrated users to another client, a browser option or a partner service. Sony instead told affected users that the app will no longer be available and that console benefits are unchanged.

The decision also fits Sony's broader PC posture in 2026. IGN reported that Sony Interactive Entertainment chief Hermen Hulst told employees the PC port programme was inconsistent and did not make enough money, and both IGN and Shacknews connected the PC app shutdown to Sony's earlier retreat from porting PlayStation exclusives to Windows. That does not prove the app failed for the same reason as the port programme, but the two moves point in the same direction: Sony is concentrating on the console, the Portal and the subscription catalog rather than spreading PlayStation experiences across general purpose computers.

Why It Matters

For subscribers, the practical effect is narrow but real. Anyone who relied on the PC app to stream the PlayStation Plus catalog on a Windows laptop or desktop loses that access on December 10, 2026. The remaining official options require hardware: a PS5, a PS4 or a PlayStation Portal. Remote Play can put a console's output on a computer, but it requires a console on the same network, so it is not a substitute for a console-free cloud service. Sony says memberships and console benefits are unaffected, which is true but does not restore the specific capability being removed.

For the cloud gaming market, the move is a reminder that catalog streaming is still tethered to hardware strategy. Microsoft's 15 hour monthly cap and GeForce Now's 100 hour allowance show that competitors are actively tuning access rather than abandoning PC players. Sony's exit from the PC app leaves those services with one less direct comparison point and leaves PlayStation Premium without a native Windows entry. That could be rational if the audience is truly negligible. It could also be self reinforcing: a product that is not promoted, not improved and not bundled prominently will struggle to attract users, and low usage then becomes the reason to close it.

For Sony, the reputational cost is likely to be larger than the direct revenue loss, because the announcement was easy to miss. A platform holder that wants to be seen as serious about cloud streaming would normally give a shutdown its own explanation, a migration path and a clear statement about what comes next. Sony gave a short paragraph inside a catalog post. The company's fans may accept the math, but the handling makes the retreat look quieter than the decision itself.

Next Up

The next fixed date is December 10, 2026, when the PlayStation Plus app on PC goes offline. Sony has said it will notify affected users directly. Before that, the November Game Catalog wave arrives on November 17, with Death Stranding 2: On the Beach, Like a Dragon: Pirate Yakuza in Hawaii, Atomfall, Dragon Quest III HD-2D Remake and the other listed titles, plus Soul Reaver 2 and Freedom Wars Remastered for Premium members.

After the shutdown, the question is whether Sony offers any new way for PC players to reach PlayStation Plus streaming, or whether cloud streaming remains confined to the console and the PlayStation Portal. Sony has announced no replacement, and its statement leaves the PC category closed for now. The company's next public test will be whether it can grow engagement on the hardware paths it is keeping, while rivals keep PC streaming in their plans.

FDA Orders NAION Eye Risk Warning on All GLP-1 Drugs, From Ozempic to Zepbound

Yanming Liu — Wed, 11 Nov 2026 19:13:53 +0000

For most of the past decade, glucagon-like peptide-1 receptor agonists have been the fastest growing class of medicines in the United States, moving from a niche treatment for type 2 diabetes into household names prescribed for weight loss, cardiovascular risk reduction, kidney protection and sleep apnea. The FDA's own labeling table now lists twelve approved products in the class, beginning with Byetta (exenatide) in 2005 and running through Victoza, Trulicity, Saxenda, Xultophy, Soliqua, Ozempic, Rybelsus, Wegovy, Mounjaro, Zepbound and, most recently, Eli Lilly's oral pill Foundayo (orforglipron), approved in 2026.

Non-arteritic anterior ischemic optic neuropathy, or NAION, is a rare condition that arises when blood flow to the front of the optic nerve is reduced. Patients typically notice sudden, painless loss of vision in one eye, and a share of them never recover fully. Its underlying cause is incompletely understood, which is precisely why it has been so difficult to determine whether the cases reported among GLP-1 users are caused by the drugs, by the diabetes and metabolic disease that many users already have, or by chance.

The signal is not new. The FDA said its review was prompted by the July 2024 Hathaway et al. study published in JAMA Ophthalmology that linked semaglutide to NAION. European regulators moved earlier. The European Medicines Agency's safety committee said in June 2025 that NAION may affect up to 1 in 10,000 people taking semaglutide for at least a year, the first time a regulator confirmed the side effect, and the United Kingdom followed in February 2026. In Denmark, four patients who experienced vision loss after using Novo Nordisk's GLP-1 drugs were granted compensation.

On November 9, 2026, the FDA converted that accumulating signal into a class-wide labeling requirement, telling manufacturers of every approved GLP-1 receptor agonist to add information about a potential increased risk of NAION to the Warnings and Precautions section of their labels. The action does not withdraw any product or restrict any indication. It requires disclosure, and it attaches clinical advice about referral and about whether to continue treatment.

Key Facts

The FDA said in a Drug Safety Communication dated November 9, 2026 that it is requiring application holders for all GLP-1 receptor agonist medications to add the NAION information to labeling. The agency described NAION as a rare condition that can cause acute, painless, decreased vision in one eye, including permanent vision loss, and said cases have been reported for all currently marketed GLP-1 RA products.

The evidentiary core is a meta-analysis of 126 randomized, controlled clinical trials across multiple GLP-1 RAs, covering 134,253 patients: 78,217 GLP-1 RA users and 56,036 comparator patients. Together those trials represent 288,879 person-years of exposure, split into 156,947 person-years for GLP-1 users and 131,932 for comparators. The analysis identified 15 probable NAION events, 10 in GLP-1 RA patients, five in placebo patients and none among patients taking other non-GLP-1 glucose-lowering drugs. Incidence worked out to 6.4 events per 100,000 person-years on GLP-1 RAs versus 3.8 per 100,000 person-years for comparators.

A separate FDA Sentinel real-world study, a retrospective cohort of adults with type 2 diabetes who started treatment between 2019 and 2024, found 26 to 32 NAION events per 100,000 person-years, with GLP-1 RAs at 30 to 32, SGLT-2 inhibitors at 31 and DPP-4 inhibitors at 26. That study found no statistically significant increase versus SGLT-2 inhibitors (hazard ratio 1.19, 95 percent confidence interval 0.91 to 1.54) but did find an increased risk versus DPP-4 inhibitors (hazard ratio 1.43, 95 percent confidence interval 1.02 to 2.01). The SGLT-2 group includes widely used medicines such as Jardiance and Farxiga.

Reuters reported on November 9, 2026 that the action covers Eli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy, and that both companies disputed a causal link. A Lilly spokesperson said the communication applies to all medicines with GLP-1 RA activity and does not reference findings specific to Lilly medicines, adding that the company is carefully evaluating the update and will respond to the FDA promptly. Novo said it continues to believe the data do not establish a cause-and-effect relationship and that it remains confident in the benefit-risk profile of its GLP-1 medicines.

Analysis

The clinical guidance attached to the labeling change is modest and practical. Clinicians should refer suspected cases promptly to an ophthalmologist, and should consider discontinuing the GLP-1 RA in patients who develop NAION unless the benefits clearly outweigh the risk. That is a long way from a withdrawal, a restriction or a boxed warning, and it reflects an evidence base in which the absolute numbers remain small.

What this really means is that the FDA has decided the signal is strong enough to require disclosure but not strong enough to require limitation. Fifteen probable events across 288,879 person-years of exposure is a thin statistical base. The comparator rate of 3.8 per 100,000 person-years also sits inside the published general-population range of 2.3 to 10.2, which undercuts any claim of a dramatic class effect.

The real-world data are more awkward for the class than the trial data. The Sentinel study's failure to show a statistically significant increase versus SGLT-2 inhibitors, alongside a significant increase versus DPP-4 inhibitors, means the observational evidence points in different directions depending on which comparator is chosen. CNBC reported on November 10, 2026 that observational studies consistently reported increased risk versus both comparators even though the Sentinel analysis did not, a discrepancy that reflects differences in confounding and follow-up. Diabetes itself is a known risk factor for NAION, and separating drug effect from underlying disease is the central methodological problem.

The mechanistic gap matters too. The FDA said animal data did not identify a mechanism, which means there is no clean biological story to anchor the epidemiology. Without one, the case rests on a small number of events reported unevenly across products, with most of the attention so far concentrated on semaglutide. Citi analyst Geoff Meacham said the action may temporarily increase patient and investor concern, but the rarity of NAION and the substantial weight, glycemic, cardiovascular, renal and sleep apnea benefits should preserve a favorable benefit-risk profile and limit changes to prescribing.

Why It Matters

Scale is the reason this is not a niche label update. Semaglutide and tirzepatide are among the most widely prescribed medicines in the world. Even a very rare adverse event becomes a public health question when millions of patients are exposed, and a warning that reaches every product in the class reaches every prescriber in the country at once. Semaglutide and tirzepatide already carry a boxed warning over thyroid C-cell tumors seen in rodents and warnings about diabetic retinopathy.

Korea Biomedical Review reported on November 11, 2026 that Korea's Ministry of Food and Drug Safety issued a safety alert on November 10 covering 38 approved drug products from four pharmaceutical companies over the potential NAION risk. The 38 products include formulations of Novo's Wegovy, Ozempic, Rybelsus, Saxenda and Xultophy FlexTouch, Lilly Korea's Mounjaro and Trulicity, Hanmi Pharmaceutical's eppe (efpeglenatide) and Sanofi-Aventis Korea's Soliqua Pen. The ministry asked companies to submit safety information and plans for potential labeling changes and said it will review them before deciding whether to revise prescribing precautions. Korea had previously received one reported NAION case following semaglutide, in January 2024, and Food and Drug Safety Minister Oh Yu-kyoung told a parliamentary audit on October 13 that NAION had already been added as a very rare adverse reaction to Wegovy and Ozempic prescribing information.

The risk of the warning is behavioral. Kim Dae-jung, a professor of endocrinology and metabolism at Ajou University Hospital, cautioned against patients discontinuing GLP-1 treatment solely because of the warning, noting that most reported cases had been associated with semaglutide rather than other drugs in the class, that only 15 cases were identified in clinical trials and that no mechanism was established in animal studies. The cardiovascular and kidney benefits, he argued, generally outweigh the risk.

Next Up

Label revisions will roll out product by product, and the FDA will face pressure to reconcile its trial-based estimate with the Sentinel findings as more real-world data accumulate. The agency has not proposed restricting prescribing and has not identified a mechanism, so the practical question is whether the warning changes clinical behavior or simply adds a line to a label that already carries significant safety text.

Other regulators are moving in parallel. Korea's review of 38 products from four companies is the first clear sign that the American decision is being exported, and the European and British precedents from 2025 and early 2026 mean the class is now under active ophthalmologic scrutiny in three major markets. The next real test is not the label language but the prescribing data: whether clinicians add an eye question to the routine GLP-1 conversation, and whether patients who develop sudden painless vision loss are referred fast enough to matter.

European Commission proposes Digital Fairness Act with fines up to 6 percent of global revenue

Yanming Liu — Wed, 11 Nov 2026 19:13:52 +0000

On November 11, 2026, the European Commission adopted a proposal for a Digital Fairness Act, a broad rewrite of online commerce rules for the platform age. The draft law would blacklist ten manipulative design practices known as dark patterns, ban loot boxes and pay-to-win mechanics for minors, require an easy cancellation button for subscriptions and give Brussels new power to fine cross-border violators up to 6 percent of global annual turnover. The package is paired with a revision of the Consumer Protection Cooperation Regulation, which would centralise enforcement of large cross-border cases.

The proposal is the most significant reform of EU consumer protection rules in more than 20 years, according to Michael McGrath, the EU commissioner for consumer protection. It would replace the 2005 Unfair Commercial Practices Directive, which was transposed into 27 national regimes, with a directly applicable regulation. That shift is meant to create one rulebook for traders that target EU consumers, wherever those companies are based. It also reflects a wider Brussels push to make platforms accountable for how their products shape user behaviour.

The scope reaches well beyond shopping carts. Under the draft, traders could not design online interfaces in ways likely to materially distort consumers' economic behaviour. A list of ten practices would be banned in all circumstances, including false claims that a product is almost sold out, pre-ticked add-ons and nagging pop-ups. Influencers would have to disclose commercial content and would be barred from exploiting children's trust. Profiling-based advertising aimed at minors would be prohibited, and personalised pricing would be restricted where it could harm minors or vulnerable consumers.

Gaming is the most politically sensitive front. Loot boxes, which simulate gambling, would be banned for under-18s, while pay-to-win and pay-to-progress mechanics would also be off limits for minors. Games that sell virtual currency would have to show its real-money value, and that currency would be disabled by default for minors unless a parent or guardian approves. Adults would keep access to loot boxes and streak mechanics, but every player would get the option to turn them off. Subscription services would face similar design duties: reminders before free trials become paid plans, renewal notices, cancellation in a few clicks and access to a human agent.

Key Facts

Reuters reported on November 11, 2026, that companies using unfair digital trade practices to push people to buy more, or targeting children with personalised advertising, would risk fines of as much as 6 percent of annual global turnover. McGrath said Brussels is not making it harder to do business but making it harder to do business unfairly. The draft still needs agreement with EU governments and the European Parliament before it can become law.

Euronews reported on November 11, 2026, that the parallel revision of the Consumer Protection Cooperation Regulation would let the Commission investigate and fine directly in large-scale cases affecting consumers in multiple countries. The power would cover cases such as the recently launched action against video game companies including Activision Blizzard. Henna Virkkunen, the executive vice president and EU tech commissioner, said the aim was to tackle new unfair commercial practices that distort consumers' choices. The 6 percent cap sits between existing regimes: the Digital Markets Act allows fines of up to 10 percent, while the Digital Services Act provides for up to 6 percent. Non-EU companies would also have to appoint a legal representative in the EU.

Digital Watch Observatory reported on November 11, 2026, that the article-by-article text covers dark patterns in Article 10, influencer marketing in Article 11, unfair personalisation in Articles 12 and 13, virtual currency in Article 14, variable rewards in Article 15, pay-to-win and pay-to-progress in Article 16 and addictive design in Article 17. The proposal would convert the Unfair Commercial Practices Directive into a directly applicable regulation, replacing 27 national regimes with one set of EU rules. Its impact assessment projects a reduction of EUR 88.4 billion in financial consumer detriment between 2025 and 2035.

The Next Web reported on November 11, 2026, that the Commission plans to repeal the 2005 directive and that any trader targeting EU consumers would fall in scope, wherever it is based. Euronews counted ten blacklisted traps, from false low-stock claims to pre-ticked add-ons and nagging pop-ups. The Commission estimates that the rules would produce EUR 13.7 billion in annual benefits, including time saved, against recurring compliance costs of EUR 678 million a year for businesses.

Politico reported on November 11, 2026, that the European Game Developer Federation and Video Games Europe attacked the proposed definition of pay-to-win as fundamentally flawed, saying it lacks clear definitions and could cover any purchase. The groups argued that the industry already regulates itself through parental controls and PEGI, which they said the Act does not take into account. Video game spending in the bloc topped EUR 27 billion last year, accounting for 17 percent of the global market, according to the European Audiovisual Observatory. Politico also reported that the 6 percent penalty would apply in cases affecting more than two-thirds of the EU population.

Analysis

What this really means is that Brussels is moving from disclosure rules and case-by-case enforcement toward direct regulation of product design. The Act does not merely ask companies to write clearer terms or label ads. It tells them which interface features are unlawful, which defaults are unacceptable for minors and which cancellation paths must exist. That is a deeper intervention than a transparency regime, because it treats the architecture of a service as a consumer protection question from the outset. The parallel enforcement overhaul reinforces the point: the Commission would no longer have to rely entirely on 27 national authorities to pursue the same cross-border conduct.

The bigger picture here is a test of whether the EU can make its single market rules coherent at the same time as it expands them. BusinessEurope Director General Markus J. Beyrer warned that the draft risks unnecessary obligations and overlapping requirements that undermine legal certainty and run counter to the EU's simplification agenda. The Commission's answer is that the benefits are large: EUR 88.4 billion in avoided consumer detriment over the decade to 2035, EUR 13.7 billion in annual benefits and EUR 678 million in yearly compliance costs. The dispute is less about whether dark patterns exist than about who should define them and how quickly the definitions can adapt.

The gaming fight shows where the drafting risk lies. The EGDF and Video Games Europe say the pay-to-win definition could reach any purchase, which would create confusion for players and developers. The Commission says it wants a thriving European games industry that competes on creativity, innovation and quality, not exploitation. That is defensible, yet the line between a legitimate progression system and a spending-maximising mechanic will be contested in the European Parliament and national capitals. How regulators will treat parental approval for virtual currency used by minors is another unresolved issue, because the proposal leaves the operational details to the wider legislative process.

Why It Matters

The EU is not a small market for companies in scope. Video game spending in the bloc topped EUR 27 billion last year, 17 percent of the global market, and the proposal would apply to any trader targeting EU consumers, including companies based outside Europe. A rule that starts with ten banned dark patterns could therefore travel through global product teams. Subscription traps alone cost consumers billions of euros every year, according to the Commission, which is why the cancellation button and free-trial reminders have drawn attention beyond Brussels.

The enforcement change may matter as much as the substantive bans. Fines of up to 6 percent of global turnover give the Commission a direct deterrent across borders. The proposal also sits alongside the Digital Markets Act and the Digital Services Act, which carry caps of 10 percent and 6 percent respectively. What this really means is that the EU is building a layered compliance stack for digital services, with consumer law, competition law and platform regulation increasingly pointing in the same direction. For companies, the cost of ignoring design risk rises sharply.

Next Up

The proposal now goes to the European Parliament and EU member states. Reuters reported that it would need agreement with both before becoming law, while The Next Web noted that years of negotiation lie ahead. The fights are visible: gaming groups want the pay-to-win definition narrowed and credit for PEGI, BusinessEurope wants fewer overlaps, and lobbying will focus on definitions and the scope of the Commission's new enforcement powers.

If adopted, the package would repeal the 2005 Unfair Commercial Practices Directive, replace 27 national regimes and give the Commission direct fining power in cross-border cases. The next signals are how quickly the Parliament and Council move, whether the ten-pattern list expands, and whether the 6 percent cap survives. For now, the direction is clear: the design tricks that built the attention economy are becoming illegal terrain in Europe.

Canada Launches Real Time Rail Instant Payments With Eight Participants and No Big Six Banks

Yanming Liu — Tue, 10 Nov 2026 15:40:11 +0000

Payments Canada launched the country's Real-Time Rail on November 9, 2026, opening a national system that lets participating financial institutions, credit unions and payment service providers exchange, clear and settle payments in real time, 24 hours a day, every day of the year. The announcement, made in Ottawa, ends a modernization effort that has been in motion since 2015 and makes Canada the last Group of Seven nation to operate a live real-time clearing and settlement system. It also makes Canada the first G7 country to require centralized fraud services from the first day of operation.

The rail arrives with an unusually short list of active participants. Eight institutions are live at launch: Wealthsimple, Questbank, Peoples Trust Company, Paramount Commerce, KOHO, DoBusiness.com, Digital Commerce Bank and Bank of America. None of Canada's Big Six banks is among them. Payments Canada says more institutions are onboarding continually, including all major Canadian financial institutions, and that the system will reach more than nine in 10 Canadians within the first year.

The project's timeline has been repeatedly reset. It was first supposed to launch in 2019, then rescheduled to 2022, pushed again to mid-2023 and delayed again to 2026. A federal budget announcement last week formally set the launch date. The Council of Canadian Innovators noted that the project was planned for 2019 and took seven years to reach this point, a gap it describes as costly for businesses waiting on cash flow and for consumers paying to move money.

Technically, the RTR runs on ISO 20022 data-rich messaging, a standard that carries more structured remittance information than older message formats. Payments Canada built the system with delivery partners CGI, Deloitte Canada, IBM Canada and Interac Corp. The nonprofit, which is 46 years old, already operates Lynx, the wholesale wire platform, and the Automated Clearing Settlement System, which handles retail debit payments, direct deposits and cheques.

Key Facts

Payments Canada said in its November 9, 2026 announcement that the C.D. Howe Institute projects the Real-Time Rail will generate up to C$14.5 billion in cost savings over the next decade, driven by lower processing costs, reduced use of cash and cheques, and reduced float. The same projection puts economic gains at C$16 billion, rising to C$27 billion as new functionalities are added to the rail.

Fraud controls are mandatory and centralized from day one, a first among G7 real-time systems. The launch bundle includes confirmation of payee for consumer accounts, a fraud transaction safety score, a risk list and repository of fraud indicators, and a fraud reporting and intelligence platform. Payments Canada frames the design as a way to put verification and intelligence at the center of the network rather than leaving each participant to build its own defenses.

Demand indicators cited by Payments Canada point to appetite beyond the launch cohort. The organization's research found that 60 percent of Canadian businesses are ready to adopt real-time payments, while 52 percent of surveyed consumers expressed interest. BetaKit reported on November 9, 2026, that Payments Canada is rolling the system out in phases to ensure continued stability, and that its launch-phase timeline targets full transaction volumes from initial participants by the third quarter of 2027.

The launch cohort spans very different kinds of institutions. Wealthsimple and KOHO are Toronto fintechs, Questbank is Questrade's new banking entity, Peoples Trust Company and Digital Commerce Bank are smaller deposit takers, Paramount Commerce and DoBusiness.com are payment firms, and Bank of America is a foreign bank. Digital Transactions News reported on November 9, 2026, that Bank of America, Digital Commerce Bank and Peoples Trust Company are among the initial participants and that major Canadian banks are expected to join later.

Analysis

The absence of the Big Six at launch is the most consequential detail in the announcement, and it is not a technical footnote. KOHO chief executive Daniel Eberhard told BetaKit that the rail would be largely performative without their participation. Wealthsimple chief compliance officer Hanna Zaidi wrote that the system can only reach its potential once every financial institution is on it. Both statements come from companies that are live on the rail, which makes them harder to dismiss as complaints from the sidelines.

The bigger picture here is that Canada has built the plumbing and validated the standards, but has not yet tested the network under the volumes that matter. A real-time rail earns its value when payroll, bill payments, insurance payouts and business-to-business invoices settle instantly across the accounts where most Canadians actually bank. Until the largest banks process at full volume, the RTR functions as a credible alternative channel for fintechs and smaller institutions rather than a replacement for the batch systems that still carry the bulk of the country's retail payments.

The phasing decision is defensible on stability grounds. Payments Canada has said it is sequencing participation to protect continued stability, and the third quarter 2027 target for full volumes from initial participants suggests the operator expects a long ramp rather than a switch flip. But the gap between a working rail and a widely used one is where previous Canadian payments modernization efforts have lost time, and the same gap is now visible in the distance between eight participants and more than nine in 10 Canadians covered.

The fraud architecture is the part of the launch that deserves more attention than it has received. Confirmation of payee, a transaction safety score, a shared risk repository and a reporting platform are centralized utilities, not features each bank can replicate cheaply. If those services work, they lower the cost of trust for every participant that joins later, which is precisely the argument for joining. The Council of Canadian Innovators said in a statement dated November 9, 2026, that payment sovereignty is economic sovereignty and that the launch is a milestone rather than a finish line.

Why It Matters

For fintechs, the rail changes the terms of access. Before the launch, Canadian innovators generally needed a bank partnership to serve customers with core payment infrastructure. The Council of Canadian Innovators said that with the RTR, Canadian fintechs will have access to core payment infrastructure for the first time without going through a bank partnership. That is a structural shift in who can build payment products in Canada, and it explains why the launch cohort leans toward fintechs and smaller institutions.

For the broader economy, the projected numbers are large enough to matter at the margin. C$14.5 billion in savings over a decade from lower processing costs, less cash and cheque use, and reduced float is a meaningful removal of friction from the system, and the C$16 billion in economic gains that could reach C$27 billion as functionality expands gives the rail a growth story rather than only a cost story. Those figures are projections from the C.D. Howe Institute, not measured outcomes, so the next several years will test them.

Canada's position among peers also shifted. Digital Transactions News reported on November 9, 2026, that the launch follows the 2023 introduction of FedNow, the Federal Reserve's US real-time payments system, and Jim Colassano of The Clearing House, which runs the US RTP network launched in November 2017, said the launch reinforces global demand for always-on payment infrastructure. Steve Mott of consultancy BetterBuy Design said the Canadian launch shows real-time rails can serve strong customer demand if the banks get moving forward, adding that the shift to real time is inexorable.

Next Up

The hard deadline to watch is the third quarter of 2027, when Payments Canada's launch-phase timeline aims for all participants in the initial launch phases to process their full transaction volumes on the RTR. The Council of Canadian Innovators has called for every Canadian financial institution to be on the rail by mid-2027, alongside progress on open banking and more opportunity for Canadian innovators to build on the system. Budget 2026 committed to a public consultation on payments priorities early next year and a review of the Canadian Payments Act.

Bank of Canada Governor Tiff Macklem said the Bank will oversee the system for safety and reliability. Finance Minister Francois-Philippe Champagne framed the launch as a foundation for a more competitive digital economy. Payments Canada chief executive Susan E. Hawkins called it a new era for payments. The next twelve months will show whether the Big Six join at the pace the operator expects, and whether a rail launched with eight participants becomes the default path for Canadian money movement or remains a parallel option.